Oil prices remain resilient as shipping risks around the Strait of Hormuz keep energy costs elevated. That keeps inflation on the radar for central banks and leaves cash yields uncertain. Reliable cash dividends start to look more appealing when policy signals are harder to read. This article highlights three stocks from the Dividend Powerhouses screener, each offering a yield above 5% with dividends that are covered, growing, and historically stable.

The three stocks covered below are just a starting sample, since the full Dividend Powerhouses screen surfaced 89 more companies with similarly compelling dividend stories that are not covered here. To identify and analyze the ideas that best match your income goals, head straight into the Dividend Powerhouses (3%+ Yield) screener.

Progressive (PGR)

Overview: Progressive is one of the largest U.S. auto and property insurers, covering personal cars, motorcycles, RVs, boats, and homes, as well as commercial vehicles, small business policies, workers’ compensation, and reinsurance. It reaches customers through independent agents, online channels, and phone sales, which gives it broad access to both individual and business clients.

Operations: Progressive generates most of its revenue from Personal Lines including property at about US$74.9b, with Commercial Lines contributing around US$10.8b and the remainder from smaller segments and adjustments, all from the United States.

Market Cap: US$125.2b

Progressive may appeal to income-focused investors because it combines a large, data heavy auto and property insurance business with profitability metrics such as a 12.8% net margin and a high forecast Return on Equity. Its edge rests on pricing and underwriting that lean heavily on analytics and telematics, which can help it stay competitive even as claim costs and regulation change. At the same time, analysts currently expect earnings pressure over the next few years and the company still leans heavily on personal auto, so concentration risk is a consideration. Mixed analyst ratings, recent insider selling and an uneven dividend history mean investors may wish to weigh valuation signals and cash flow strength against these potential risk factors.

Progressive’s data heavy edge and 12.8% net margin could be masking a very different risk and reward profile than headline sentiment suggests. Get the full picture in the 2 key rewards and 3 important warning signs (1 is major!)

Build your own Progressive style dividend shortlist

Progressive and the two other high yielding stocks in this article all came from a single Simply Wall St screen, but the real opportunity is in tailoring the filters to what matters most to you. Use our flexible Screener to mix dividend strength, valuation, quality and risk checks, or jump straight into our curated Investing Ideas for ready made starting points.

Accenture (ACN)

Overview: Accenture is a global consulting and IT services company that helps large businesses and public sector clients redesign how they work using cloud, data, AI, cybersecurity, automation, and outsourced operations. It works across sectors from banks and insurers to healthcare, consumer brands, telecoms, energy, and governments, often running critical processes and technology for these clients.

Operations: Accenture generates most of its revenue from its Products segment at about US$22.3b, followed by Health & Public Service at roughly US$14.9b, Financial Services at about US$13.8b, Communications, Media & Technology at around US$12.4b, and Resources at roughly US$9.8b.

Market Cap: US$107.5b

Income investors may want to keep Accenture on the radar because it combines a 3.71% dividend yield and high quality earnings with a business that sits at the heart of enterprise AI, cloud, and cybersecurity spending. The stock has lagged the wider US market and management has trimmed revenue growth guidance, while bookings softness, AI disruption risk, and workforce restructuring costs show that this is not a simple growth story. Yet return on equity around the mid 20% range, a P/E below both the US market and sector average, and deep relationships with blue chip and government clients mean the current valuation reflects a lot of caution. The key question is how AI will ultimately affect Accenture’s role within its clients’ operations.

Accenture’s stalled share price and trimmed growth guidance may be masking a more interesting twist. See how its mid 20% return on equity and client relationships stack up in the analysis report for Accenture.

Medtronic (MDT)

Overview: Medtronic is a large medical device company that supplies hospitals and clinicians with products such as heart pacemakers and defibrillators, spine and brain implants, surgical tools and robotics, and diabetes devices used in operating rooms and chronic disease care around the world.

Operations: Medtronic generates most of its revenue from Cardiovascular at about US$14.0b, Neuroscience at roughly US$10.3b, and Medical Surgical at around US$8.8b, with smaller contributions from Other and unallocated items.

Market Cap: US$111.6b

Medtronic gives dividend focused investors a blend of medical technology exposure and income, with a yield above 3% and 49 consecutive years of dividend increases as of June 2026. The company is pushing hard into AI powered surgery, robotics and new cardiac ablation platforms, supported by recent CE marks, FDA Breakthrough designations and targeted acquisitions. Forecast earnings growth is described as stronger than its recent track record, although revenue growth expectations are characterized as more moderate and return on equity at 9.7% leaves room for improvement. Funding relies heavily on external borrowing and some segments, such as Diabetes and parts of Medical Surgical, face margin and execution pressures. The key question is whether product pipeline progress and restructuring efforts can translate into higher quality growth that the current valuation anticipates.

Medtronic’s push into AI powered surgery and robotics could reshape how its 49 year dividend record is valued. See how the growth story lines up with the risks in the analyst forecasts for Medtronic

Seeking Alternatives Beyond These Dividends

Fresh ideas move first. Stocks gaining early breakout momentum can get away quickly while slower investors stay caught watching from the sidelines. Scan what is still under the radar for now and act now.

• Spot stronger balance sheets before they are widely talked about by scanning our curated list of solid balance sheet and fundamentals (48 results) while it still flies under most investors' radar.
• Ride potential AI momentum instead of watching from the sidelines by checking a hand picked mix of 71 profitable AI stocks that aren't just burning cash that already generate real earnings.
• Position ahead of possible infrastructure tailwinds by reviewing a focused pool of 37 power grid technology and infrastructure stocks while sentiment is still building rather than fully priced in.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.